USNU — US Neurosurgical Holdings Income Statement
0.000.00%
Last trade - 00:00- $6.96m
- $5.21m
Annual income statement for US Neurosurgical Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K/A | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 3.07 | 3.17 | 1.06 | 0 | 0 |
| Cost of Revenue | |||||
| Gross Profit | 2.72 | 2.81 | 0.975 | 0 | — |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 1.58 | 1.56 | 1.15 | 1.39 | 0.765 |
| Operating Profit | 1.49 | 1.61 | -0.088 | -1.39 | -0.765 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 0.151 | 0.856 | -0.553 | -1.53 | -0.816 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 0.142 | 0.533 | -0.973 | -1.57 | -0.816 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 0.142 | 0.533 | -0.881 | -1.34 | -0.816 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 0.142 | 0.533 | -0.881 | -1.34 | -0.816 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.018 | 0.068 | -0.113 | -0.17 | -0.088 |